Today: 11 June 2026
Fluence Energy stock jumps 16% to kick off 2026 as AI-power demand lifts storage names

Fluence Energy stock jumps 16% to kick off 2026 as AI-power demand lifts storage names

NEW YORK, Jan 3, 2026, 18:36 ET — Market closed

  • Fluence Energy surged 16.3% in the latest session, ending Friday at $23.01.
  • The move came as investors leaned into “AI infrastructure” themes and value pockets tied to power demand.
  • Focus now shifts to February earnings expectations, rates and next week’s U.S. macro data.

Shares of Fluence Energy Inc (FLNC) jumped 16.3% on Friday to close at $23.01, after trading as high as $23.12 and as low as $20.14. The stock was up about 0.4% in after-hours trading, StockAnalysis data showed.

The rally put the battery-storage name back in focus as U.S. equities opened 2026 with a mixed session and investors debated the interest-rate path. “Value is outperforming growth and AI infrastructure is up,” said Jed Ellerbroek, a portfolio manager at Argent Capital in St. Louis. Reuters

Energy storage has increasingly been pulled into the AI power-demand story, as data centres add load and the grid needs more flexible capacity to manage peaks. A Reuters Breakingviews column this week said the energy storage surge is being fueled by demand from AI data centres.

Fluence sells battery energy storage systems, or BESS — large battery packs used on the grid — and software used to optimize renewables and storage. The company operates in 47 markets globally, Reuters data shows.

Peers tied to storage and solar were mixed on the day. Stem climbed about 13% and Sunrun rose about 5.6%, while Tesla fell about 2.6%.

Fluence’s move also comes against the backdrop of its fiscal 2026 targets laid out in late November, when the company guided for revenue of $3.2 billion to $3.6 billion and adjusted EBITDA of $40 million to $60 million. Adjusted EBITDA is a profitability measure that excludes items such as interest, taxes and some non-recurring costs; Fluence also said about 85% of the midpoint of its revenue outlook was covered by backlog, the contracted orders not yet delivered.

For investors, the next question is whether the stock’s early-year momentum reflects a durable shift in demand expectations or a fast repositioning trade after a soft year-end tape. Execution — turning backlog into shipped projects while protecting margins — remains the key test.

Before Monday’s reopening of U.S. markets, traders will be watching incoming U.S. economic data and any fresh moves in Treasury yields, which can quickly reset risk appetite for rate-sensitive growth shares.

Fluence is expected to report earnings on Feb. 9, based on market-calendar estimates, putting added weight on management’s commentary on pricing, project timing and any revisions to the fiscal 2026 outlook. Investors will also look for updates on recurring software revenue and liquidity as projects move from order to installation.

Technically, Friday’s spike left the stock with a near-term ceiling around the $23 area after it opened near $20.36. A slide back below the $20 level would put the late-December closing range back in focus.

With markets shut for the weekend, attention turns to whether Friday’s surge draws follow-through buying in the next regular session — or fades if the broader “AI infrastructure” rotation loses traction.

Stock Market Today

  • AMD Stock Price Forecast: Analyst Lowers Target Amid AI Market Caution
    June 11, 2026, 11:00 AM EDT. Shares of Advanced Micro Devices (AMD) have surged 111% year-to-date, driven by investor optimism over its expanding role in the artificial intelligence (AI) sector. Despite the strong performance, a prominent AI-focused analyst has trimmed the price target for AMD, signaling caution about the chipmaker's near-term prospects. The analyst cited concerns over competitive pressures and potential market saturation. AMD's growth is largely tied to its ability to capture demand in AI computing, a fast-evolving field requiring specialized semiconductor technology. Investors are weighing the company's robust sales against risks from supply chain constraints and intensifying industry competition.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
MARA stock jumps 10% as bitcoin miners rebound — what traders watch before Monday
Previous Story

MARA stock jumps 10% as bitcoin miners rebound — what traders watch before Monday

Tesco issues urgent “do not eat” recall for three pate lines after date-label error
Next Story

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

Go toTop